,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['trastuzumab']
i was at when trastuzumab was 1st presented for the tt of met disease, making a big dif for pts worldwide, later moving to earlier lines. today i witnessed the #onctwitter standing o to tdxd. proud to be an oncologist and to be here in this moment.
Passionate oncologist. CMO @CarismaTher #CARmacrophages for cancer treatment https://t.co/pBNjpNCox5 BOD @americancancer @tigerlilycares @wearearovella